Phreesia, Inc. (NYSE:PHR) Shares Purchased by Bessemer Group Inc.

Bessemer Group Inc. increased its holdings in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 23.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 47,758 shares of the company's stock after purchasing an additional 8,978 shares during the period. Bessemer Group Inc. owned 0.08% of Phreesia worth $1,222,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of PHR. Johnson Financial Group Inc. raised its stake in shares of Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after acquiring an additional 896 shares in the last quarter. Quarry LP grew its holdings in shares of Phreesia by 210.9% during the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after buying an additional 1,923 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of Phreesia by 154.6% during the fourth quarter. Smartleaf Asset Management LLC now owns 3,442 shares of the company's stock valued at $89,000 after buying an additional 2,090 shares during the last quarter. NewEdge Advisors LLC increased its position in shares of Phreesia by 12.1% in the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock valued at $107,000 after acquiring an additional 459 shares during the period. Finally, Tower Research Capital LLC TRC raised its stake in Phreesia by 1,023.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,660 shares of the company's stock worth $142,000 after acquiring an additional 5,156 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on PHR shares. Canaccord Genuity Group reduced their price objective on Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a research note on Thursday, May 29th. Citigroup reissued a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. Truist Financial upped their price objective on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. KeyCorp decreased their target price on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Finally, Wall Street Zen raised shares of Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $31.64.

Insider Activity

In related news, General Counsel Allison C. Hoffman sold 6,024 shares of Phreesia stock in a transaction dated Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total value of $143,672.40. Following the sale, the general counsel directly owned 143,830 shares in the company, valued at approximately $3,430,345.50. The trade was a 4.02% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Balaji Gandhi sold 8,045 shares of the firm's stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total value of $191,873.25. Following the completion of the transaction, the chief financial officer owned 108,411 shares in the company, valued at approximately $2,585,602.35. This trade represents a 6.91% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 50,605 shares of company stock worth $1,256,069. Company insiders own 5.50% of the company's stock.

Phreesia Price Performance

NYSE PHR traded down $0.15 during trading hours on Tuesday, reaching $28.32. The company's stock had a trading volume of 40,761 shares, compared to its average volume of 452,766. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53. The company's 50-day moving average is $25.64 and its two-hundred day moving average is $26.15. The firm has a market capitalization of $1.68 billion, a price-to-earnings ratio of -38.36 and a beta of 0.68.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $115.94 million for the quarter, compared to analysts' expectations of $115.00 million. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The firm's revenue for the quarter was up 14.5% compared to the same quarter last year. During the same quarter last year, the company earned ($0.05) EPS. On average, equities analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.